Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.
D000606:Amino Sugars / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001835:Body Weight; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006027:Glycosides / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D009279:Naphthacenes / Q000008:administration & dosage / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D013997:Time Factors
D000606:Amino Sugars; D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D009279:Naphthacenes; D003630:Daunorubicin